Predicting the recurrence of hepatocellular carcinoma (≤ 5 cm) after resection surgery with promising risk factors: habitat fraction of tumor and its peritumoral micro-environment

Purpose Characterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to predict the recurrence-free survival (RFS) of HCC (≤ 5 cm) with habitat imaging of HCC and its peritumoral micro-environment. Material and Methods...

Full description

Saved in:
Bibliographic Details
Published inRadiologia medica Vol. 128; no. 10; pp. 1181 - 1191
Main Authors Zhang, Yunfei, Yang, Chun, Sheng, Ruofan, Dai, Yongming, Zeng, Mengsu
Format Journal Article
LanguageEnglish
Published Milan Springer Milan 01.10.2023
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Purpose Characterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to predict the recurrence-free survival (RFS) of HCC (≤ 5 cm) with habitat imaging of HCC and its peritumoral micro-environment. Material and Methods A total of 264 patients with HCC were included. Taking advantage of the enhancement ratio at the arterial and hepatobiliary phase of contrast-enhanced MRI, all HCCs and their peritumoral tissue of 3 mm and 4 mm were encoded with different habitats. Besides, the quantitative fraction of each habitat of HCC and peritumoral tissue were calculated. Univariable and multivariable Cox regression analysis was performed to select the prognostic factors. The nomogram-based predictor was established. Kaplan–Meier analysis was conducted to stratify the recurrence risk. Fivefold cross-validation was performed to determine the predictive performance with the concordance index (C-Index). Decision curve analysis was used to evaluate the net benefit. Results Qualitatively, the spatial distribution of the habitats varied for different survival outcomes. Quantitatively, the fraction of habitat 3 in peritumoral tissue of 4 mm (f 3 -P 4 ) was selected as independent risk factors (OR = 89.2, 95% CI = 14.5–549.2, p  < 0.001) together with other two clinical variables. Integrating both clinical variables and f 3 -P 4 , a nomogram was constructed and showed high predictive efficacy (C-Index: 0.735, 95% CI 0.617–0.854) and extra net benefit according to the decision curve. Furthermore, patients with low f 3 -P 4 or risk score given by nomogram have far longer RFS than those with high f 3 -P 4 or risk score (stratification by f 3 -P 4 : 131.9 vs 55.0 months and stratification by risk score:131.9 vs 34.1 months). Conclusion Habitat imaging of HCC and peritumoral microenvironment can be used for effectively and non-invasively estimating the RFS, which holds potential in guiding clinical management and decision making.
AbstractList Characterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to predict the recurrence-free survival (RFS) of HCC (≤ 5 cm) with habitat imaging of HCC and its peritumoral micro-environment.PURPOSECharacterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to predict the recurrence-free survival (RFS) of HCC (≤ 5 cm) with habitat imaging of HCC and its peritumoral micro-environment.A total of 264 patients with HCC were included. Taking advantage of the enhancement ratio at the arterial and hepatobiliary phase of contrast-enhanced MRI, all HCCs and their peritumoral tissue of 3 mm and 4 mm were encoded with different habitats. Besides, the quantitative fraction of each habitat of HCC and peritumoral tissue were calculated. Univariable and multivariable Cox regression analysis was performed to select the prognostic factors. The nomogram-based predictor was established. Kaplan-Meier analysis was conducted to stratify the recurrence risk. Fivefold cross-validation was performed to determine the predictive performance with the concordance index (C-Index). Decision curve analysis was used to evaluate the net benefit.MATERIAL AND METHODSA total of 264 patients with HCC were included. Taking advantage of the enhancement ratio at the arterial and hepatobiliary phase of contrast-enhanced MRI, all HCCs and their peritumoral tissue of 3 mm and 4 mm were encoded with different habitats. Besides, the quantitative fraction of each habitat of HCC and peritumoral tissue were calculated. Univariable and multivariable Cox regression analysis was performed to select the prognostic factors. The nomogram-based predictor was established. Kaplan-Meier analysis was conducted to stratify the recurrence risk. Fivefold cross-validation was performed to determine the predictive performance with the concordance index (C-Index). Decision curve analysis was used to evaluate the net benefit.Qualitatively, the spatial distribution of the habitats varied for different survival outcomes. Quantitatively, the fraction of habitat 3 in peritumoral tissue of 4 mm (f3-P4) was selected as independent risk factors (OR = 89.2, 95% CI = 14.5-549.2, p < 0.001) together with other two clinical variables. Integrating both clinical variables and f3-P4, a nomogram was constructed and showed high predictive efficacy (C-Index: 0.735, 95% CI 0.617-0.854) and extra net benefit according to the decision curve. Furthermore, patients with low f3-P4 or risk score given by nomogram have far longer RFS than those with high f3-P4 or risk score (stratification by f3-P4: 131.9 vs 55.0 months and stratification by risk score:131.9 vs 34.1 months).RESULTSQualitatively, the spatial distribution of the habitats varied for different survival outcomes. Quantitatively, the fraction of habitat 3 in peritumoral tissue of 4 mm (f3-P4) was selected as independent risk factors (OR = 89.2, 95% CI = 14.5-549.2, p < 0.001) together with other two clinical variables. Integrating both clinical variables and f3-P4, a nomogram was constructed and showed high predictive efficacy (C-Index: 0.735, 95% CI 0.617-0.854) and extra net benefit according to the decision curve. Furthermore, patients with low f3-P4 or risk score given by nomogram have far longer RFS than those with high f3-P4 or risk score (stratification by f3-P4: 131.9 vs 55.0 months and stratification by risk score:131.9 vs 34.1 months).Habitat imaging of HCC and peritumoral microenvironment can be used for effectively and non-invasively estimating the RFS, which holds potential in guiding clinical management and decision making.CONCLUSIONHabitat imaging of HCC and peritumoral microenvironment can be used for effectively and non-invasively estimating the RFS, which holds potential in guiding clinical management and decision making.
PurposeCharacterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to predict the recurrence-free survival (RFS) of HCC (≤ 5 cm) with habitat imaging of HCC and its peritumoral micro-environment.Material and MethodsA total of 264 patients with HCC were included. Taking advantage of the enhancement ratio at the arterial and hepatobiliary phase of contrast-enhanced MRI, all HCCs and their peritumoral tissue of 3 mm and 4 mm were encoded with different habitats. Besides, the quantitative fraction of each habitat of HCC and peritumoral tissue were calculated. Univariable and multivariable Cox regression analysis was performed to select the prognostic factors. The nomogram-based predictor was established. Kaplan–Meier analysis was conducted to stratify the recurrence risk. Fivefold cross-validation was performed to determine the predictive performance with the concordance index (C-Index). Decision curve analysis was used to evaluate the net benefit.ResultsQualitatively, the spatial distribution of the habitats varied for different survival outcomes. Quantitatively, the fraction of habitat 3 in peritumoral tissue of 4 mm (f3-P4) was selected as independent risk factors (OR = 89.2, 95% CI = 14.5–549.2, p < 0.001) together with other two clinical variables. Integrating both clinical variables and f3-P4, a nomogram was constructed and showed high predictive efficacy (C-Index: 0.735, 95% CI 0.617–0.854) and extra net benefit according to the decision curve. Furthermore, patients with low f3-P4 or risk score given by nomogram have far longer RFS than those with high f3-P4 or risk score (stratification by f3-P4: 131.9 vs 55.0 months and stratification by risk score:131.9 vs 34.1 months).ConclusionHabitat imaging of HCC and peritumoral microenvironment can be used for effectively and non-invasively estimating the RFS, which holds potential in guiding clinical management and decision making.
Purpose Characterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to predict the recurrence-free survival (RFS) of HCC (≤ 5 cm) with habitat imaging of HCC and its peritumoral micro-environment. Material and Methods A total of 264 patients with HCC were included. Taking advantage of the enhancement ratio at the arterial and hepatobiliary phase of contrast-enhanced MRI, all HCCs and their peritumoral tissue of 3 mm and 4 mm were encoded with different habitats. Besides, the quantitative fraction of each habitat of HCC and peritumoral tissue were calculated. Univariable and multivariable Cox regression analysis was performed to select the prognostic factors. The nomogram-based predictor was established. Kaplan–Meier analysis was conducted to stratify the recurrence risk. Fivefold cross-validation was performed to determine the predictive performance with the concordance index (C-Index). Decision curve analysis was used to evaluate the net benefit. Results Qualitatively, the spatial distribution of the habitats varied for different survival outcomes. Quantitatively, the fraction of habitat 3 in peritumoral tissue of 4 mm (f 3 -P 4 ) was selected as independent risk factors (OR = 89.2, 95% CI = 14.5–549.2, p  < 0.001) together with other two clinical variables. Integrating both clinical variables and f 3 -P 4 , a nomogram was constructed and showed high predictive efficacy (C-Index: 0.735, 95% CI 0.617–0.854) and extra net benefit according to the decision curve. Furthermore, patients with low f 3 -P 4 or risk score given by nomogram have far longer RFS than those with high f 3 -P 4 or risk score (stratification by f 3 -P 4 : 131.9 vs 55.0 months and stratification by risk score:131.9 vs 34.1 months). Conclusion Habitat imaging of HCC and peritumoral microenvironment can be used for effectively and non-invasively estimating the RFS, which holds potential in guiding clinical management and decision making.
Characterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to predict the recurrence-free survival (RFS) of HCC (≤ 5 cm) with habitat imaging of HCC and its peritumoral micro-environment. A total of 264 patients with HCC were included. Taking advantage of the enhancement ratio at the arterial and hepatobiliary phase of contrast-enhanced MRI, all HCCs and their peritumoral tissue of 3 mm and 4 mm were encoded with different habitats. Besides, the quantitative fraction of each habitat of HCC and peritumoral tissue were calculated. Univariable and multivariable Cox regression analysis was performed to select the prognostic factors. The nomogram-based predictor was established. Kaplan-Meier analysis was conducted to stratify the recurrence risk. Fivefold cross-validation was performed to determine the predictive performance with the concordance index (C-Index). Decision curve analysis was used to evaluate the net benefit. Qualitatively, the spatial distribution of the habitats varied for different survival outcomes. Quantitatively, the fraction of habitat 3 in peritumoral tissue of 4 mm (f -P ) was selected as independent risk factors (OR = 89.2, 95% CI = 14.5-549.2, p < 0.001) together with other two clinical variables. Integrating both clinical variables and f -P , a nomogram was constructed and showed high predictive efficacy (C-Index: 0.735, 95% CI 0.617-0.854) and extra net benefit according to the decision curve. Furthermore, patients with low f -P or risk score given by nomogram have far longer RFS than those with high f -P or risk score (stratification by f -P : 131.9 vs 55.0 months and stratification by risk score:131.9 vs 34.1 months). Habitat imaging of HCC and peritumoral microenvironment can be used for effectively and non-invasively estimating the RFS, which holds potential in guiding clinical management and decision making.
Author Zhang, Yunfei
Sheng, Ruofan
Yang, Chun
Zeng, Mengsu
Dai, Yongming
Author_xml – sequence: 1
  givenname: Yunfei
  surname: Zhang
  fullname: Zhang, Yunfei
  organization: Shanghai Institute of Medical Imaging, Fudan University, Department of Radiology, Zhongshan Hospital, Fudan University
– sequence: 2
  givenname: Chun
  surname: Yang
  fullname: Yang, Chun
  organization: Shanghai Institute of Medical Imaging, Fudan University, Department of Radiology, Zhongshan Hospital, Fudan University
– sequence: 3
  givenname: Ruofan
  surname: Sheng
  fullname: Sheng, Ruofan
  organization: Department of Radiology, Zhongshan Hospital, Fudan University
– sequence: 4
  givenname: Yongming
  surname: Dai
  fullname: Dai, Yongming
  email: daiyongming5555@163.com
  organization: School of Biomedical Engineering, ShanghaiTech University
– sequence: 5
  givenname: Mengsu
  surname: Zeng
  fullname: Zeng, Mengsu
  email: zengmengsu111@163.com
  organization: Shanghai Institute of Medical Imaging, Fudan University, Department of Radiology, Zhongshan Hospital, Fudan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37597123$$D View this record in MEDLINE/PubMed
BookMark eNp9kTtuFjEUhS0URB6wAQpkiSYUA7ZnPA86FPGSIkEB9eiO5zq_w4z9c-0BpaPNLihYBDVLyUrwnwkPUVDZsr9zro_PIdvzwSNj96V4LIVonkQpddUUQpWFkHWni_oWO5Ctqou6a8u9v_b77DDGcyEqIUV3h-2Xje4aqcoD9v0t4ehMcv6Mpw1yQrMQoTfIg-Ub3EIKBqdpmYC4ATLOhxn48dXlt6svl_rHVzM_4mATUpZGzEbB87jQGdIF_-zShm8pzC7u_MnFD9yCSYHiU76BwSVI3BKsqjwvLXMgDn7kLkW-RXLXJzDx2RkKBfpPjoKf0ae77LaFKeK9m_WIvX_x_N3Jq-L0zcvXJ89OC5NDpgI6JQQIW45aW1nVgFbUnTBa6cYaJTtTj8YqYa1uZdWgHoQcYMQOmgrsMJRH7Hj1zTk-LhhTn9PsfgQ8hiX2qtVlV1VtrTP68B_0PCzk8-sy1ShV6aqVmVIrlQPFSGj7LbkZ6KKXot_12q-99rnX_rrXvs6iBzfWyzDj-Fvyq8gMlCsQ85XPv_9n9n9sfwIUt7cz
CitedBy_id crossref_primary_10_1177_02841851241229185
crossref_primary_10_1002_jmri_29433
Cites_doi 10.1016/j.jhep.2017.04.024
10.1148/ryai.2020190168
10.1080/15548627.2018.1474994
10.1016/j.jhep.2019.05.005
10.3892/or.2017.5738
10.1186/s12964-020-0530-4
10.1007/s12072-020-10032-2
10.1007/s00330-014-3108-y
10.1148/radiol.2017170845
10.1007/s00261-012-9952-9
10.1016/j.mri.2011.05.007
10.3390/brainsci11020200
10.1007/s11605-018-3927-2
10.3748/wjg.v20.i20.5935
10.1111/cas.15609
10.1016/j.mri.2014.02.017
10.1056/NEJMra1713263
10.1016/j.ejrad.2015.12.015
10.1148/radiol.2017170554
10.1002/cac2.12010
10.1109/ICCIMA.2007.328
ContentType Journal Article
Copyright Italian Society of Medical Radiology 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. Italian Society of Medical Radiology.
Copyright_xml – notice: Italian Society of Medical Radiology 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. Italian Society of Medical Radiology.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1007/s11547-023-01695-6
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1826-6983
EndPage 1191
ExternalDocumentID 10_1007_s11547_023_01695_6
37597123
Genre Journal Article
GrantInformation_xml – fundername: Clinical Research Project of Zhongshan Hospital, Fudan University
  grantid: 2020ZSLC61
– fundername: Clinical Research Plan of SHDC
  grantid: SHDC2020CR1029B
– fundername: National Natural Science Foundation of China
  grantid: 82171897
  funderid: http://dx.doi.org/10.13039/501100001809
– fundername: Shanghai Municipal Key Clinical Specialty
  grantid: shslczdzk03202
– fundername: National Natural Science Foundation of China
  grantid: 82171897
GroupedDBID -5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
203
29P
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5VS
67Z
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAFGU
AAHNG
AAIAL
AAJKR
AANXM
AANZL
AAPBV
AARHV
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKAS
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACSNA
ACTTH
ACVWB
ACWMK
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADMDM
ADOXG
ADQRH
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFTE
AEGAL
AEGNC
AEGXH
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFLOW
AFNRJ
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGBP
AGJBK
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BDATZ
BGNMA
CAG
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
HF~
HG5
HG6
HLICF
HMJXF
HRMNR
HVGLF
HZ~
IHE
IJ-
IKXTQ
IMOTQ
ITM
IWAJR
IXC
IXE
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KDC
KOV
KPH
LLZTM
M4Y
MA-
N2Q
NB0
NPVJJ
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
PT4
QOR
QOS
R89
R9I
RIG
RNS
ROL
RPX
RSV
S16
S1Z
S27
S37
S3B
SAP
SDH
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WK8
YLTOR
Z45
Z7U
Z7X
Z82
Z87
ZA5
ZMTXR
ZOVNA
~A9
~S-
AACDK
AAJBT
AASML
ABAKF
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
CGR
CUY
CVF
ECM
EIF
H13
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c375t-a9200a0f3d55f146aef0690c5257fc219c6dcf20ff58147e5b01bade9a74afbb3
IEDL.DBID AGYKE
ISSN 1826-6983
0033-8362
IngestDate Wed Aug 28 17:01:38 EDT 2024
Fri Sep 13 05:05:39 EDT 2024
Thu Sep 12 19:17:47 EDT 2024
Wed Oct 09 10:12:53 EDT 2024
Sat Dec 16 12:04:35 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Habitat imaging
Hepatocellular carcinoma
Recurrence-free survival
Peritumoral micro-environment
Language English
License 2023. Italian Society of Medical Radiology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-a9200a0f3d55f146aef0690c5257fc219c6dcf20ff58147e5b01bade9a74afbb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 37597123
PQID 2872245481
PQPubID 2043526
PageCount 11
ParticipantIDs proquest_miscellaneous_2853944865
proquest_journals_2872245481
crossref_primary_10_1007_s11547_023_01695_6
pubmed_primary_37597123
springer_journals_10_1007_s11547_023_01695_6
PublicationCentury 2000
PublicationDate 2023-10-01
PublicationDateYYYYMMDD 2023-10-01
PublicationDate_xml – month: 10
  year: 2023
  text: 2023-10-01
  day: 01
PublicationDecade 2020
PublicationPlace Milan
PublicationPlace_xml – name: Milan
– name: Italy
– name: Torino
PublicationSubtitle Official Journal of the Italian Society of Medical and Interventional Radiology
PublicationTitle Radiologia medica
PublicationTitleAbbrev Radiol med
PublicationTitleAlternate Radiol Med
PublicationYear 2023
Publisher Springer Milan
Springer Nature B.V
Publisher_xml – name: Springer Milan
– name: Springer Nature B.V
References Matsushima, Sato, Yamaura, Kato, Kinosada, Era, Takahashi (CR18) 2014; 32
Villanueva (CR3) 2019; 380
Sung, Ferlay, Siegel, Laversanne, Soerjomataram, Jemal, Bray (CR2) 2021; 71
Kim, Choi, Byun, Kang, Lim, Lee, Kim (CR15) 2019; 71
Yamamoto, Kasashima, Fukui, Tsujio, Yashiro, Maeda (CR22) 2023; 114
Altieri, Barbagallo, Certo, Broggi, Ragusa, Di Pietro, Caltabiano (CR11) 2021; 11
Baghban, Roshangar, Jahanban-Esfahlan, Seidi, Ebrahimi-Kalan, Jaymand, Kolahian (CR25) 2020; 18
Tang, Bashir, Corwin, Cruite, Dietrich, Do, Ehman (CR7) 2018; 286
CR12
Zhang, Wang, Sun, Deng, Wu, Ma, Li (CR23) 2020; 40
Verma, Correa, Hill, Statsevych, Bera, Beig, Mahammedi (CR6) 2020; 2
Colecchia, Schiumerini, Cucchetti, Cescon, Taddia, Marasco, Festi (CR19) 2014; 20
Risom, Glass, Averbukh, Liu, Baranski, Kagel, McCaffrey (CR24) 2022; 185
Motosugi, Ichikawa, Oguri, Sano, Sou, Muhi, Matsuda (CR17) 2011; 29
Juan-Albarracín, Fuster-Garcia, Pérez-Girbés, Aparici-Robles, Alberich-Bayarri, Revert-Ventura, Martí-Bonmatí (CR5) 2018; 287
Chen, Zhang, Lu, Li, Chen, Wen, Jia (CR20) 2020; 14
Siegel, Miller, Wagle, Jemal (CR1) 2023; 73
Liang, Zhao, Xie, Li, Yin, Cheng, Wang (CR8) 2016; 85
Bartolozzi, Battaglia, Bargellini, Bozzi, Campani, Pollina, Filipponi (CR13) 2013; 38
Ren, Leng, Fan, Pan, Li, Wu, Wu (CR10) 2017; 38
Verloh, Haimerl, Zeman, Schlabeck, Barreiros, Loss, Schreyer (CR16) 2014; 24
Gillies, Balagurunathan (CR4) 2018; 288
Chen, Ning, Li, Wei, Lao, Wang, Wu (CR9) 2018; 14
Jung, Kim, Choi, Kwon, Yi, Lee, Suh (CR21) 2019; 23
Lee, Kim, Lee, Sinn, Park (CR14) 2017; 67
Y Yamamoto (1695_CR22) 2023; 114
RJ Gillies (1695_CR4) 2018; 288
D-P Chen (1695_CR9) 2018; 14
Z-H Chen (1695_CR20) 2020; 14
A Colecchia (1695_CR19) 2014; 20
U Motosugi (1695_CR17) 2011; 29
R Baghban (1695_CR25) 2020; 18
W Zhang (1695_CR23) 2020; 40
S Matsushima (1695_CR18) 2014; 32
H Sung (1695_CR2) 2021; 71
1695_CR12
DH Kim (1695_CR15) 2019; 71
N Verloh (1695_CR16) 2014; 24
RL Siegel (1695_CR1) 2023; 73
S-M Jung (1695_CR21) 2019; 23
R Verma (1695_CR6) 2020; 2
C-X Ren (1695_CR10) 2017; 38
A Tang (1695_CR7) 2018; 286
R Altieri (1695_CR11) 2021; 11
A Villanueva (1695_CR3) 2019; 380
C Bartolozzi (1695_CR13) 2013; 38
T Risom (1695_CR24) 2022; 185
M Liang (1695_CR8) 2016; 85
J Juan-Albarracín (1695_CR5) 2018; 287
S Lee (1695_CR14) 2017; 67
References_xml – volume: 67
  start-page: 526
  year: 2017
  end-page: 534
  ident: CR14
  article-title: Preoperative gadoxetic acid–enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.04.024
  contributor:
    fullname: Park
– volume: 73
  start-page: 17
  year: 2023
  end-page: 48
  ident: CR1
  article-title: Cancer statistics, 2023
  publication-title: CA: Cancer J Clin
  contributor:
    fullname: Jemal
– volume: 2
  start-page: e190168
  year: 2020
  ident: CR6
  article-title: Tumor habitat–derived radiomic features at pretreatment MRI that are prognostic for progression-free survival in glioblastoma are associated with key morphologic attributes at histopathologic examination: a feasibility study
  publication-title: Radiol Artif Intell
  doi: 10.1148/ryai.2020190168
  contributor:
    fullname: Mahammedi
– ident: CR12
– volume: 185
  issue: 299–310
  year: 2022
  ident: CR24
  article-title: Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma
  publication-title: Cell
  contributor:
    fullname: McCaffrey
– volume: 14
  start-page: 1335
  year: 2018
  end-page: 1346
  ident: CR9
  article-title: Peritumoral monocytes induce cancer cell autophagy to facilitate the progression of human hepatocellular carcinoma
  publication-title: Autophagy
  doi: 10.1080/15548627.2018.1474994
  contributor:
    fullname: Wu
– volume: 71
  start-page: 534
  year: 2019
  end-page: 542
  ident: CR15
  article-title: Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2019.05.005
  contributor:
    fullname: Kim
– volume: 38
  start-page: 886
  year: 2017
  end-page: 898
  ident: CR10
  article-title: Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value
  publication-title: Oncol Rep
  doi: 10.3892/or.2017.5738
  contributor:
    fullname: Wu
– volume: 71
  start-page: 209
  year: 2021
  end-page: 249
  ident: CR2
  article-title: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA: Cancer J Clin
  contributor:
    fullname: Bray
– volume: 18
  start-page: 1
  year: 2020
  end-page: 19
  ident: CR25
  article-title: Tumor microenvironment complexity and therapeutic implications at a glance
  publication-title: Cell Commun Signal
  doi: 10.1186/s12964-020-0530-4
  contributor:
    fullname: Kolahian
– volume: 14
  start-page: 754
  year: 2020
  end-page: 764
  ident: CR20
  article-title: Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study
  publication-title: Hep Intl
  doi: 10.1007/s12072-020-10032-2
  contributor:
    fullname: Jia
– volume: 24
  start-page: 1013
  year: 2014
  end-page: 1019
  ident: CR16
  article-title: Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla
  publication-title: Eur Radiol
  doi: 10.1007/s00330-014-3108-y
  contributor:
    fullname: Schreyer
– volume: 287
  start-page: 944
  year: 2018
  end-page: 954
  ident: CR5
  article-title: Glioblastoma: vascular habitats detected at preoperative dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging predict survival
  publication-title: Radiology
  doi: 10.1148/radiol.2017170845
  contributor:
    fullname: Martí-Bonmatí
– volume: 38
  start-page: 290
  year: 2013
  end-page: 296
  ident: CR13
  article-title: Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers
  publication-title: Abdom Imaging
  doi: 10.1007/s00261-012-9952-9
  contributor:
    fullname: Filipponi
– volume: 29
  start-page: 1047
  year: 2011
  end-page: 1052
  ident: CR17
  article-title: Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index
  publication-title: Magn Reson Imaging
  doi: 10.1016/j.mri.2011.05.007
  contributor:
    fullname: Matsuda
– volume: 11
  start-page: 200
  year: 2021
  ident: CR11
  article-title: Peritumoral microenvironment in high-grade gliomas: from flairectomy to microglia–glioma cross-talk
  publication-title: Brain Sci
  doi: 10.3390/brainsci11020200
  contributor:
    fullname: Caltabiano
– volume: 23
  start-page: 304
  year: 2019
  end-page: 311
  ident: CR21
  article-title: Characteristics of early recurrence after curative liver resection for solitary hepatocellular carcinoma
  publication-title: J Gastrointest Surg
  doi: 10.1007/s11605-018-3927-2
  contributor:
    fullname: Suh
– volume: 20
  start-page: 5935
  year: 2014
  ident: CR19
  article-title: Prognostic factors for hepatocellular carcinoma recurrence
  publication-title: World J Gastroenterol: WJG
  doi: 10.3748/wjg.v20.i20.5935
  contributor:
    fullname: Festi
– volume: 114
  start-page: 16
  year: 2023
  end-page: 24
  ident: CR22
  article-title: The heterogeneity of cancer-associated fibroblast subpopulations: their origins, biomarkers, and roles in the tumor microenvironment
  publication-title: Cancer Sci
  doi: 10.1111/cas.15609
  contributor:
    fullname: Maeda
– volume: 32
  start-page: 654
  year: 2014
  end-page: 659
  ident: CR18
  article-title: Visualization of liver uptake function using the uptake contrast-enhanced ratio in hepatobiliary phase imaging
  publication-title: Magn Reson Imaging
  doi: 10.1016/j.mri.2014.02.017
  contributor:
    fullname: Takahashi
– volume: 380
  start-page: 1450
  year: 2019
  end-page: 1462
  ident: CR3
  article-title: Hepatocellular carcinoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1713263
  contributor:
    fullname: Villanueva
– volume: 85
  start-page: 546
  year: 2016
  end-page: 552
  ident: CR8
  article-title: MR liver imaging with Gd-EOB-DTPA: the need for different delay times of the hepatobiliary phase in patients with different liver function
  publication-title: Eur J Radiol
  doi: 10.1016/j.ejrad.2015.12.015
  contributor:
    fullname: Wang
– volume: 288
  start-page: 36
  issue: 1
  year: 2018
  end-page: 37
  ident: CR4
  article-title: Perfusion MR imaging of breast cancer: insights using “habitat imaging”
  publication-title: Radiol Soc N Am
  contributor:
    fullname: Balagurunathan
– volume: 286
  start-page: 29
  year: 2018
  end-page: 48
  ident: CR7
  article-title: Evidence supporting LI-RADS major features for CT-and MR imaging–based diagnosis of hepatocellular carcinoma: a systematic review
  publication-title: Radiology
  doi: 10.1148/radiol.2017170554
  contributor:
    fullname: Ehman
– volume: 40
  start-page: 69
  year: 2020
  end-page: 80
  ident: CR23
  article-title: CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target
  publication-title: Cancer Commun
  doi: 10.1002/cac2.12010
  contributor:
    fullname: Li
– volume: 11
  start-page: 200
  year: 2021
  ident: 1695_CR11
  publication-title: Brain Sci
  doi: 10.3390/brainsci11020200
  contributor:
    fullname: R Altieri
– volume: 2
  start-page: e190168
  year: 2020
  ident: 1695_CR6
  publication-title: Radiol Artif Intell
  doi: 10.1148/ryai.2020190168
  contributor:
    fullname: R Verma
– volume: 18
  start-page: 1
  year: 2020
  ident: 1695_CR25
  publication-title: Cell Commun Signal
  doi: 10.1186/s12964-020-0530-4
  contributor:
    fullname: R Baghban
– ident: 1695_CR12
  doi: 10.1109/ICCIMA.2007.328
– volume: 32
  start-page: 654
  year: 2014
  ident: 1695_CR18
  publication-title: Magn Reson Imaging
  doi: 10.1016/j.mri.2014.02.017
  contributor:
    fullname: S Matsushima
– volume: 71
  start-page: 534
  year: 2019
  ident: 1695_CR15
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2019.05.005
  contributor:
    fullname: DH Kim
– volume: 29
  start-page: 1047
  year: 2011
  ident: 1695_CR17
  publication-title: Magn Reson Imaging
  doi: 10.1016/j.mri.2011.05.007
  contributor:
    fullname: U Motosugi
– volume: 287
  start-page: 944
  year: 2018
  ident: 1695_CR5
  publication-title: Radiology
  doi: 10.1148/radiol.2017170845
  contributor:
    fullname: J Juan-Albarracín
– volume: 14
  start-page: 754
  year: 2020
  ident: 1695_CR20
  publication-title: Hep Intl
  doi: 10.1007/s12072-020-10032-2
  contributor:
    fullname: Z-H Chen
– volume: 73
  start-page: 17
  year: 2023
  ident: 1695_CR1
  publication-title: CA: Cancer J Clin
  contributor:
    fullname: RL Siegel
– volume: 67
  start-page: 526
  year: 2017
  ident: 1695_CR14
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2017.04.024
  contributor:
    fullname: S Lee
– volume: 85
  start-page: 546
  year: 2016
  ident: 1695_CR8
  publication-title: Eur J Radiol
  doi: 10.1016/j.ejrad.2015.12.015
  contributor:
    fullname: M Liang
– volume: 40
  start-page: 69
  year: 2020
  ident: 1695_CR23
  publication-title: Cancer Commun
  doi: 10.1002/cac2.12010
  contributor:
    fullname: W Zhang
– volume: 288
  start-page: 36
  issue: 1
  year: 2018
  ident: 1695_CR4
  publication-title: Radiol Soc N Am
  contributor:
    fullname: RJ Gillies
– volume: 24
  start-page: 1013
  year: 2014
  ident: 1695_CR16
  publication-title: Eur Radiol
  doi: 10.1007/s00330-014-3108-y
  contributor:
    fullname: N Verloh
– volume: 114
  start-page: 16
  year: 2023
  ident: 1695_CR22
  publication-title: Cancer Sci
  doi: 10.1111/cas.15609
  contributor:
    fullname: Y Yamamoto
– volume: 38
  start-page: 886
  year: 2017
  ident: 1695_CR10
  publication-title: Oncol Rep
  doi: 10.3892/or.2017.5738
  contributor:
    fullname: C-X Ren
– volume: 14
  start-page: 1335
  year: 2018
  ident: 1695_CR9
  publication-title: Autophagy
  doi: 10.1080/15548627.2018.1474994
  contributor:
    fullname: D-P Chen
– volume: 23
  start-page: 304
  year: 2019
  ident: 1695_CR21
  publication-title: J Gastrointest Surg
  doi: 10.1007/s11605-018-3927-2
  contributor:
    fullname: S-M Jung
– volume: 20
  start-page: 5935
  year: 2014
  ident: 1695_CR19
  publication-title: World J Gastroenterol: WJG
  doi: 10.3748/wjg.v20.i20.5935
  contributor:
    fullname: A Colecchia
– volume: 38
  start-page: 290
  year: 2013
  ident: 1695_CR13
  publication-title: Abdom Imaging
  doi: 10.1007/s00261-012-9952-9
  contributor:
    fullname: C Bartolozzi
– volume: 185
  issue: 299–310
  year: 2022
  ident: 1695_CR24
  publication-title: Cell
  contributor:
    fullname: T Risom
– volume: 71
  start-page: 209
  year: 2021
  ident: 1695_CR2
  publication-title: CA: Cancer J Clin
  contributor:
    fullname: H Sung
– volume: 380
  start-page: 1450
  year: 2019
  ident: 1695_CR3
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1713263
  contributor:
    fullname: A Villanueva
– volume: 286
  start-page: 29
  year: 2018
  ident: 1695_CR7
  publication-title: Radiology
  doi: 10.1148/radiol.2017170554
  contributor:
    fullname: A Tang
SSID ssj0040109
Score 2.3936632
Snippet Purpose Characterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to...
Characterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to predict the...
PurposeCharacterizing the composition of hepatocellular carcinoma (HCC) and peritumoral micro-environment may provide sensitive biomarkers. We aimed to predict...
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1181
SubjectTerms Abdominal Radiology
Adult
Aged
Biomarkers
Carcinoma, Hepatocellular - diagnostic imaging
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - surgery
Contrast Media
Decision analysis
Decision making
Diagnostic Radiology
Female
Habitats
Hepatectomy
Humans
Imaging
Interventional Radiology
Liver cancer
Liver Neoplasms - diagnostic imaging
Liver Neoplasms - pathology
Liver Neoplasms - surgery
Magnetic Resonance Imaging - methods
Male
Mathematical analysis
Medical imaging
Medical prognosis
Medicine
Medicine & Public Health
Middle Aged
Neoplasm Recurrence, Local - diagnostic imaging
Neuroradiology
Nomograms
Performance prediction
Predictive Value of Tests
Prognosis
Radiology
Regression analysis
Retrospective Studies
Risk Factors
Spatial distribution
Survival
Tumor Microenvironment
Ultrasound
Title Predicting the recurrence of hepatocellular carcinoma (≤ 5 cm) after resection surgery with promising risk factors: habitat fraction of tumor and its peritumoral micro-environment
URI https://link.springer.com/article/10.1007/s11547-023-01695-6
https://www.ncbi.nlm.nih.gov/pubmed/37597123
https://www.proquest.com/docview/2872245481/abstract/
https://www.proquest.com/docview/2853944865/abstract/
Volume 128
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwEB7RrYS40PKfUqpB4gACV5sfx5veVqilAhVx6ErlFDmOrSK0CcpmL5y49i048BCceZQ-CTNO0gUtHHqL8mPHmbFn4pnvG4BnRWZiaYpUyLGLROJ0KHSprCDvOVaZU9Z5-uKT9-nxLHl7Js9WOG6f7D5EJP1CvcK6kbFXgkyMYAIRKdIN2JRclnoEm9M3H98dDgtwwtGeHh_z7yf_tkFrjuVaUNTbmqMtOB0QO12Kyef9ZVvsm6_rBI7XGcY23O59T5x2ynIHbtjqLtw86aPr9-Dnh4aPOREayS_EhvfiPRoQa4fnZLjamjf6OXMVDRchquq5xueXFz8uv13IX9_N_AX6ouPIoCaPmMBFh7tG3vBFGhHpFbfPKe3YF_s5QGYLJ68XXdPhLLi_djmvG9RViZ_aBTIhsz9DA5hzEqH4A6J3H2ZHh6evj0Vf2UGYWMlW6Iwmpx67uJTSkQi1dcyYbJia1RlaRE1aGheNnZOTMFFWFuOw0KXNtEq0K4r4AYyqurKPACemdJHKDL2xTcJSFz6QFKYRWX9l9SSAl4Os8y8dgUe-ompmYeQkjNwLI08D2B3UIe8n8yKnn0pydOjXLgzg6dVl-lz8yXVl6yXfIxliPEllAA87NbrqjoacKfIQAng16MSq8f-_y871bn8MtyJWK59ouAujtlnaJ-QwtcVeP0H2YGMWTX8DKxEVqQ
link.rule.ids 315,786,790,27957,27958,41116,41558,42185,42627,52146,52269
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV07b9RAEB5BkIAmCq_EIYFBogDBSufHes_poojogFxEkZPSWev1rpLi7Mjn62nzL1LkR1DzU_JLmFnbOVCgoLP82IfHnpndme8bgLdFZmJpilTIkYtE4nQodKmsIO85VplT1nn64ulxOpklX07laQ8KWwzZ7kNI0mvqFdiNrL0SZGMEM4hIkd6HB8ynzkuuWbQ_6N-Egz09PObvz_1pgu74lXdiot7UHG7Aeu8j4n4n1Cdwz1ZP4eG0j4I_gx_fGj7mhGUk_w0b3jP3qD2sHZ6RgWlr3pDnDFM0XCyoquca391cXt98v5Q_r8z8Pfri4MjgI49swEWHj0bemEUaLcmf2-fUc-yL8uwhs3qTd4qu6fAQ3F-7nNcN6qrE83aBTJzsz9AE5pzsJ36D0j2H2eGnk4OJ6CswCBMr2Qqd0U-kRy4upXSkU7V1zGxsmELVGVJ2Ji2Ni0bOyXGYKCuLUVjo0mZaJdoVRfwC1qq6sluAY1O6SGWGRmyTsNSFD_iEaURWWlk9DuDDIJT8oiPayFeUyizCnESYexHmaQA7g9zy_qdb5LT4I4eElmBhAG9uL9Pr4leuK1sv-R7JUOBxKgPY7OR92x1NOVNkyQP4OHwAq8b_PZbt_7v9NTyanEyP8qPPx19fwmMuX98lB-7AWtss7S45OW3xyn_TvwBy__uL
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB5BK1Vc-KcECgwSBxC43fw43nCroEuhtOqBSuUUOY4tENqkymYvnLj2LTjwEJx5lD4JM07SLRQOiFuUOIl_xp4vmfk-AzwqMhNLU6RCjlwkEqdDoUtlBaHnWGVOWefli3f30u2D5M2hPDzD4vfZ7kNIsuM0sEpT1W4clW5jQXwjz68E-RvBaiJSpBdhOaFpSza-vPnq_c7WsBonHPrpyTJ_vvNXh3QOZZ6LkHrHM7kCeqhyl2_yaX3eFuvm829qjv_TpqtwuUeluNmZ0TW4YKvrsLLbx91vwPf9ho85RRoJMWLDf-k9TxBrhx_IpbU1hwA4pxUNb09U1VONj0-Ov518OZY_vprpE_TbkSPTnTyXAmcdIxv5VzBS88ji-Pmc7I79NkDPkXXECQ-jazoGBr-vnU_rBnVV4sd2hizV7M9QA6acXijOkPduwsFk692LbdHv-SBMrGQrdEbTVo9cXErpaBXX1rGWsmHRVmdoeTVpaVw0ck6Ow0RZWYzCQpc20yrRrijiW7BU1ZW9DTg2pYtUZqjGNglLXfgQU5hGhAuU1eMAng4Dnx910h75QsSZByOnwcj9YORpAGuDbeT9NJ_l9LlJEIg--sIAHp5epu7iLteVredcRjL5eJzKAFY7mzp9HTU5U4QdAng22Mfi4X-vy51_K_4AVvZfTvK3r_d27sKliC3MZyOuwVLbzO09QlVtcb-fOD8B-Swhbw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predicting+the+recurrence+of+hepatocellular+carcinoma+%28%E2%89%A4%E2%80%895%C2%A0cm%29+after+resection+surgery+with+promising+risk+factors%3A+habitat+fraction+of+tumor+and+its+peritumoral+micro-environment&rft.jtitle=Radiologia+medica&rft.au=Zhang%2C+Yunfei&rft.au=Yang%2C+Chun&rft.au=Sheng%2C+Ruofan&rft.au=Dai%2C+Yongming&rft.date=2023-10-01&rft.eissn=1826-6983&rft.volume=128&rft.issue=10&rft.spage=1181&rft_id=info:doi/10.1007%2Fs11547-023-01695-6&rft_id=info%3Apmid%2F37597123&rft.externalDocID=37597123
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1826-6983&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1826-6983&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1826-6983&client=summon